Tuesday, May 05, 2026 12:49:51 AM
Tut tut tut… I asked an LLM if your message was actually truthful.
ChatGPT says: You’ve taken a couple of timeline points and stretched them into sweeping conclusions. “Old tech” and “patents expired” don’t prove something doesn’t work—they just describe age and IP status. Jumping from that to “nothing of substance” is opinion, not fact.
Grok says: This is the usual trick—stack a few loosely true statements, then bolt on a big conclusion like it’s inevitable. It isn’t. Age of a technology and profitability claims don’t magically equal “snake oil.”
Claude says: The argument conflates separate issues: development timelines, patent status, and commercial performance. These factors alone cannot establish whether a technology is effective or not.
Copilot says: The post presents selective points as definitive proof. Without evidence directly addressing performance or outcomes, the conclusion remains speculative rather than factual.
ChatGPT says: You’ve taken a couple of timeline points and stretched them into sweeping conclusions. “Old tech” and “patents expired” don’t prove something doesn’t work—they just describe age and IP status. Jumping from that to “nothing of substance” is opinion, not fact.
Grok says: This is the usual trick—stack a few loosely true statements, then bolt on a big conclusion like it’s inevitable. It isn’t. Age of a technology and profitability claims don’t magically equal “snake oil.”
Claude says: The argument conflates separate issues: development timelines, patent status, and commercial performance. These factors alone cannot establish whether a technology is effective or not.
Copilot says: The post presents selective points as definitive proof. Without evidence directly addressing performance or outcomes, the conclusion remains speculative rather than factual.
Recent RDGL News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:45:22 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
